AVENUE THERAPEUTICS, INC. Proceeds from Issuance of Private Placement
AVENUE THERAPEUTICS, INC. (ATXI) reported Proceeds from Issuance of Private Placement of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-11-14
- AVENUE THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2023-03-31 was $3.10M.
- AVENUE THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $12.01M.
- AVENUE THERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2022-03-31 was $0.00.
- AVENUE THERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2022 was $12.01M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement as first filed | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |||||
| 2023-09-30 | $550.00K 10-Q · filed 2024-11-14 | |||||
| 2023-09-08 | $600.00K 10-K · filed 2024-03-18 | $550.00K 10-Q · filed 2023-11-13 | ||||
| 2023-03-31 | $3.10M 10-Q · filed 2023-05-12 | $15.11M derived: sum of 2 quarters · filed 2023-05-12 | ||||
| 2022-12-31 | $12.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.01M 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | |||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 |